PeterLabs Holdings Bhd
KLSE:PLABS
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.108
0.245
|
Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PLABS stock under the Base Case scenario is 0.39 MYR. Compared to the current market price of 0.17 MYR, PeterLabs Holdings Bhd is Undervalued by 56%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
PeterLabs Holdings Bhd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PLABS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
PeterLabs Holdings Bhd
Balance Sheet Decomposition
PeterLabs Holdings Bhd
Current Assets | 84.3m |
Cash & Short-Term Investments | 17.5m |
Receivables | 39.3m |
Other Current Assets | 27.4m |
Non-Current Assets | 36.5m |
Long-Term Investments | 971k |
PP&E | 25.1m |
Intangibles | 10m |
Other Non-Current Assets | 420k |
Current Liabilities | 36.5m |
Accounts Payable | 11.7m |
Other Current Liabilities | 24.8m |
Non-Current Liabilities | 6.1m |
Long-Term Debt | 2.3m |
Other Non-Current Liabilities | 3.9m |
Earnings Waterfall
PeterLabs Holdings Bhd
Revenue
|
181.7m
MYR
|
Cost of Revenue
|
-158.9m
MYR
|
Gross Profit
|
22.8m
MYR
|
Operating Expenses
|
-16.7m
MYR
|
Operating Income
|
6.1m
MYR
|
Other Expenses
|
-2.7m
MYR
|
Net Income
|
3.4m
MYR
|
Free Cash Flow Analysis
PeterLabs Holdings Bhd
MYR | |
Free Cash Flow | MYR |
PLABS Profitability Score
Profitability Due Diligence
PeterLabs Holdings Bhd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
PeterLabs Holdings Bhd's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
PLABS Solvency Score
Solvency Due Diligence
PeterLabs Holdings Bhd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Score
PeterLabs Holdings Bhd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PLABS Price Targets Summary
PeterLabs Holdings Bhd
Dividends
Current shareholder yield for PLABS is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
PeterLabs Holdings Bhd.is an investment company, which engages in the manufacture, distribution and trading of animal health and nutrition products. The company is headquartered in Nilai, Negeri Sembilan. The company went IPO on 2011-07-26. The firm is engaged in the manufacturing, distribution and trading of animal health and nutrition products. Its segments include Manufacturing and Trading. The Manufacturing segment is engaged in the manufacturing of animal health and nutrition products. The Trading segment is engaged in the trading and distribution of animal health and nutrition products. Its products include biosecurity and disinfectant, compound feed supplement, feed additives, nutritional premix, pharmaceutical and water-soluble supplement. The firm provides technical information exchange with its customer’s supervisors, technicians and in-house veterinarians, livestock information sharing, post-mortem on diseased animals, blood sampling of diseased animals for testing and individualize latest technologies in the manufacture of feed additives for feed and farming industry.
Contact
IPO
Employees
Officers
The intrinsic value of one PLABS stock under the Base Case scenario is 0.39 MYR.
Compared to the current market price of 0.17 MYR, PeterLabs Holdings Bhd is Undervalued by 56%.